The stock's rise snapped a three-day losing streak.

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Amgen (AMGN – Research Report), with a price target of ...

In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other cheap NASDAQ stocks. On April 10, Dan Ives, Head of Global Tech Research at Wedbush Securities ...

Cantor Fitzgerald downgraded Amgen (AMGN) to Neutral from Overweight.Stay Ahead of the Market: Discover outperforming stocks and invest ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

In a fresh update, Bloomberg has reported that US biotech Amgen Inc. has agreed to purchase Dublin-based Horizon Therapeutics Plc. for €24.7 billion ($26bn), in a deal which could yet see ...